Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Cancer Res. 2017 May 16;77(13):3455–3466. doi: 10.1158/0008-5472.CAN-16-3240

Figure 6.

Figure 6

Tumor initiation frequency of SUM159PT cells pre-treated with enzalutamide. A, schematic of experimental design. B, Tumor initiation frequency. Top, luciferase activity, measured as total flux, in mice injected with 102–104 cells pre-treated for 3 days with vehicle control (Veh) or enzalutamide (Enza). Bottom, summary of the number of mice per group with tumors as determined by palpation (left) and luciferase activity/total flux (right).